Form 4: Astronics Executive Mulato Sells ATRO Shares
Insider Transaction Report
James Mulato, President of Astronics Test Systems, reported the sale of 12,187 shares of Astronics Corp. common and Class B stock.
Summary
- James Mulato, President of Astronics Test Systems, reported the sale of 9,734 shares of $.01 PV Common Stock and 2,453 shares of $.01 PV Class B Stock on December 1, 2025.
- The shares were sold at a price of $53.24 per share.
- Following the transaction, Mulato beneficially owns 27,077.822 shares of $.01 PV Common Stock.
- Mulato holds various stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates between December 14, 2026, and December 7, 2033.
- Mulato also holds Restricted Stock Units (RSUs) with target numbers of 18,550, 11,500, and 17,700 shares, which vest based on Astronics Corp.'s average annual adjusted EBITDA performance over specified periods.
Sentiment
Score: 3
Explanation: The sale of shares by a key executive generally signals a negative sentiment or a belief that the stock is adequately valued. However, the executive retains substantial equity interests through options and performance-based restricted stock units, which are tied to future company performance, mitigating extreme negativity.
Positives
- Continued significant holdings of stock options and restricted stock units align management interests with shareholder value.
- Restricted Stock Unit vesting is tied to Astronics Corp.'s average annual adjusted EBITDA performance, incentivizing operational profitability and long-term value creation.
Negatives
- An insider, James Mulato, sold a total of 12,187 shares of Astronics Corp. common and Class B stock.
- The sale occurred at a price of $53.24 per share, which could be interpreted as the executive believing the stock is fully valued or a lack of confidence in short-term prospects.
Risks
- The vesting of 18,550 target restricted stock units is contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024, to December 31, 2026, with vesting between 50% and 150% of target.
- The vesting of 11,500 target restricted stock units is contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2023, to December 31, 2025, with vesting between 75% and 115% of target.
- The vesting of 17,700 target restricted stock units is contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025, to December 31, 2027, with vesting between 50% and 150% of target.
- These performance-based vesting conditions introduce uncertainty regarding the final number of shares to be received.
Future Outlook
The vesting of a significant portion of executive compensation, specifically restricted stock units, is tied to Astronics Corp.'s future average annual adjusted EBITDA performance through December 31, 2027. This indicates a strategic focus on long-term operational profitability and value creation.
Industry Context
This Form 4 filing, detailing an insider stock transaction, does not provide direct information on broader industry trends or competitors. It primarily reflects an individual executive's equity activity within Astronics Corp.
Stakeholder Impact
- Shareholders may view the insider sale negatively, potentially impacting investor confidence and the company's stock price.
- The executive's continued significant holdings of performance-based equity awards align management's long-term interests with shareholder value creation.
Next Steps
- Monitor the vesting of 11,500 target restricted stock units on February 23, 2026, contingent on 2023-2025 adjusted EBITDA performance.
- Monitor the vesting of 18,550 target restricted stock units on February 22, 2027, contingent on 2024-2026 adjusted EBITDA performance.
- Monitor the vesting of 17,700 target restricted stock units on February 27, 2028, contingent on 2025-2027 adjusted EBITDA performance.
Key Dates
| Date | Description |
|---|---|
| 12/14/2017 | Date exercisable for certain stock options. |
| 12/12/2018 | Date exercisable for certain stock options. |
| 12/13/2019 | Date exercisable for certain stock options. |
| 12/09/2020 | Date exercisable for certain stock options. |
| 01/22/2022 | Date exercisable for certain stock options. |
| 12/09/2022 | Date exercisable for certain stock options. |
| 12/16/2023 | Date exercisable for certain stock options. |
| 01/01/2023 | Start of performance period for 11,500 target restricted stock units. |
| 12/07/2024 | Date exercisable for certain stock options. |
| 01/01/2024 | Start of performance period for 18,550 target restricted stock units. |
| 01/01/2025 | Start of performance period for 17,700 target restricted stock units. |
| 12/01/2025 | Transaction date for the sale of common and Class B stock. |
| 12/03/2025 | Signature date of the Form 4 filing. |
| 12/31/2025 | End of performance period for 11,500 target restricted stock units. |
| 02/23/2026 | Potential vesting date for 11,500 target restricted stock units. |
| 12/14/2026 | Expiration date for certain stock options. |
| 12/31/2026 | End of performance period for 18,550 target restricted stock units. |
| 02/22/2027 | Potential vesting date for 18,550 target restricted stock units. |
| 12/12/2027 | Expiration date for certain stock options. |
| 12/31/2027 | End of performance period for 17,700 target restricted stock units. |
| 02/27/2028 | Potential vesting date for 17,700 target restricted stock units. |
| 12/13/2028 | Expiration date for certain stock options. |
| 12/09/2029 | Expiration date for certain stock options. |
| 01/22/2031 | Expiration date for certain stock options. |
| 12/09/2031 | Expiration date for certain stock options. |
| 12/16/2032 | Expiration date for certain stock options. |
| 12/07/2033 | Expiration date for certain stock options. |
Recommendation
holdWhile the insider sale by a key executive is a negative signal, the amount sold is not exceptionally large relative to the executive's total holdings, which still include substantial options and performance-based restricted stock units. These remaining holdings tie the executive's incentives to the company's future performance, particularly adjusted EBITDA. Investors should monitor future performance and additional insider activity, but a 'hold' recommendation is appropriate given the mixed signals and the executive's continued significant stake.
Keywords
Astronics Corp, ATRO, Form 4, insider trading, stock sale, common stock, Class B stock, stock options, restricted stock units, RSU, EBITDA, executive compensation, James Mulato
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.